Related Experiment Videos
Teriparatide - Indications beyond osteoporosis
Marilyn Lee Cheng1, Vishal Gupta
1Department of Endocrinology, Khoo Teck Puat Hospital, 90 Yishun Central, Singapore.
Indian Journal of Endocrinology and Metabolism
|May 26, 2012
Summary
Teriparatide, a parathyroid hormone (PTH) anabolic agent, improves bone strength in osteoporosis. This review explores its benefits beyond current uses, including fracture healing and dental health.
Area of Science:
- Endocrinology
- Bone Biology
- Pharmacology
Background:
- Osteoporosis is characterized by impaired bone strength and increased fracture risk.
- Current treatments include antiresorptive bisphosphonates and anabolic agents like teriparatide.
- Teriparatide, a parathyroid hormone (PTH) analog, stimulates bone formation, enhancing bone mass and quality.
Purpose of the Study:
- To review the established and potential benefits of teriparatide therapy.
- To explore teriparatide's efficacy in indications beyond its current FDA-approved uses.
- To discuss teriparatide's role in fracture healing, dental stability, and managing conditions like osteonecrosis of the jaw, hypoparathyroidism, and hypocalcemia.
Main Methods:
- Literature review of studies on teriparatide and parathyroid hormone (PTH).
- Analysis of clinical trial data and case reports.
- Synthesis of evidence regarding teriparatide's pharmacological effects and clinical applications.
Main Results:
- Teriparatide effectively increases bone mineral density and reduces fracture risk in osteoporosis.
- Emerging evidence suggests teriparatide may accelerate fracture healing.
- Potential benefits are indicated for dental implant stability and in managing hypoparathyroidism and hypocalcemia.
Conclusions:
- Teriparatide is a valuable anabolic agent for osteoporosis treatment.
- Further research is warranted to confirm teriparatide's efficacy in expanded indications.
- Teriparatide offers a promising therapeutic option for various bone-related conditions.
Related Concept Videos
01:40Bone Remodeling
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
01:17Hormones and Bone Tissue
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:31Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
00:59The Parathyroid Glands
The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...